|Time: 24 hrs|
|Market Price: N/A||Blueprints Price:15,000|
|Bio Lab Research 3,000|
|Time: 72 hrs|
|x1 x3 x10 x30 x100|
Characteristics[edit | edit source]
This weapon deals primarily Slash damage.
- High Slash damage – effective against health.
- Slam Radial Damage deals Toxin damage, bypassing Shields and Proto Shields.
- Decent critical chance.
- Second highest status chance of all whips, behind Galvacord/ Secura Lecta.
- Stance slot has polarity, matching the Coiling Viper.
- Innate polarity.
- Low Impact and Puncture – less effective against shields and armor.
- Slam Attack has innate Toxin damage – less effective against Machinery, Robotics, and Fossilized.
- Tied with Lecta and Secura Lecta for the lowest critical multiplier of all whips.
Weapon Loadouts[edit source]
- See Category:Scoliac Build to see how players mod this weapon.
- See Category:Scoliac Guides for guides on how to use this weapon effectively.
- For more general help with weapons, you may wish to browse Category:Weapon Guides.
Notes[edit | edit source]
- The Slam Radial Damage has a 29% chance to inflict the Toxin status effect, but is unaffected by status chance mods.
Trivia[edit | edit source]
- The Scoliac's name may be derived from Scoliosis (derived from Ancient Greek σκολίωσις skoliosis “obliquity, bending”), a medical condition in which a person's spine is curved unnaturally.
- The Scoliac was the first whip revealed, shown in Livestream 14. However it was introduced after the Lecta.
- When the Infested lab was revamped the Scoliac's model could be seen in a container, along with the Embolist, shortly before the Scoliac was actually added into the game.
- This is the second whip to be added to the game (following the Lecta), and the third research melee weapon available (following the Prova and the Dual Ichor).
Gallery[edit | edit source]
Media[edit | edit source]
Patch History[edit | edit source]
Last updated: Update 26.0
See Also[edit | edit source]
|Weapons • Damage • Compare All • Cosmetics|
Community content is available under CC-BY-SA unless otherwise noted.